Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04806165 · ClinicalTrials.gov registry record · NA

Treatment Uptake Chatbot for Eating Disorders

A NA study of Eating Disorders, sponsored by Washington University School of Medicine.

Completed
Registry status
NA
Development phase
205
Enrollment target
1
Study location

NCT04806165: Completed NA study of Eating Disorders, sponsored by Washington University School of Medicine.

NCT04806165 is a NA study of Eating Disorders that has completed, run by Washington University School of Medicine. The registered enrollment target is 205 participants, below the 317-participant average among 37 other Eating Disorders trials with a reported enrollment target (35% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04806165, a NA study of Eating Disorders, has completed, sponsored by Washington University School of Medicine.

COMPLETED
Registry status
NA
Development phase
205 participants
Enrollment target
1
Study location

Study Summary

Eating disorders (EDs) are serious mental illnesses associated with high morbidity and mortality, clinical impairment, and comorbid psychopathology. Although evidence-based treatments for EDs have been established, the treatment gap is wide. Indeed, \<20% of individuals with EDs receive treatment. There is need for a novel solution not only to identify individuals with EDs but also to encourage mental health services use and to address treatment barriers. This study aims to implement a conversational agent or "chatbot" that is optimized to increase mental health services use among individuals with EDs through such features as: 1) education on the seriousness and consequences of EDs; 2) engaging the user in motivational interviewing to overcome barriers to care; 3) providing a personalized recommendation for seeking intervention; 4) repeated check-ins with the user to encourage follow-up with care. This study will utilize a randomized optimization trial with adults who have completed screening on the National Eating Disorders Association (NEDA) website and screen positive for an ED but are not in treatment to determine chatbot feasibility and to generate data on the effect of the chatbot on motivation for treatment and mental health services use. This trial will employ the Multiphase Optimization Strategy framework, using a 2\^4 full factorial design, to randomly assign participants to a combination of the four proposed intervention components (n=16 conditions) to isolate the active ingredients.

Primary Outcome

Treatment utilization was measured at each follow-up time point (2, 6, and 14 weeks), which was assessed via the prompt, "Have you tried or used any type of mental health help (e.g., self-help app, telehealth/in-person counseling, etc.) for your concerns related to your eating, shape, or weight in the past \[2, 6, or 14\] weeks?". We defined a participant as having utilized treatment at the first time they responded, "yes" (vs. "no") to this question. The data presented below indicate the rates

Conditions Studied

Interventions

  • BEHAVIORAL Motivational Interviewing
  • BEHAVIORAL Repeated Administration
  • BEHAVIORAL Personalized Recommendation
  • BEHAVIORAL Core Modules Only
  • BEHAVIORAL Motivational Interviewing, Personalized Recommendation, Repeated Administration

Study Locations (1)

Missouri

  • Washington University School of Medicine - St Louis

Trial Details

FieldValue
Enrollment Target 205 participants
Start Date 2021-03-09
Est. Completion 2022-05-09
Phase NA

What the finished NCT04806165 record still lists

NCT04806165 is an interventional study that assigns participants to a tested intervention. The registered 205 participants enrollment target is mid-sized for trials with a published cap, below the 317-participant average among 37 other Eating Disorders trials with a reported enrollment target (35% lower).

The record links to 1 condition, with Eating Disorders appearing as the primary indexed condition, and to 5 interventions - of which Motivational Interviewing is the first listed.

NCT04806165 reports a single indexed study location in Missouri.

Frequently Asked Questions

What is clinical trial NCT04806165 about?

NCT04806165 is a clinical study titled "Treatment Uptake Chatbot for Eating Disorders". Eating disorders (EDs) are serious mental illnesses associated with high morbidity and mortality, clinical impairment, and comorbid psychopathology. Although evidence-based treatments for EDs have been established, the treatment gap is wide. Indeed, \<20% of individuals with EDs receive treatment. T...

What is the current status of trial NCT04806165?

This trial is currently completed. It is a NA study. The enrollment target is 205 participants. The study started on 2021-03-09. Estimated completion is 2022-05-09.

What conditions does trial NCT04806165 study?

This clinical trial studies the following conditions: Eating Disorders.

What interventions are being tested in trial NCT04806165?

The interventions under investigation include: Motivational Interviewing (BEHAVIORAL), Repeated Administration (BEHAVIORAL), Personalized Recommendation (BEHAVIORAL), Core Modules Only (BEHAVIORAL), Motivational Interviewing, Personalized Recommendation, Repeated Administration (BEHAVIORAL).

Who is sponsoring clinical trial NCT04806165?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04806165 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Eating Disorders

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04806165's enrollment target sits among peer trials

205 12th of 37 higher than 26 of 37 other Eating Disorders trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Eating Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03457493 · 205 participants · Phase 1

    The University of Alabama At Birmingham (UAB) Neuroinflammation in Parkinson's Disease-TSPO- Positron Emission Tomography (PET) Substudy

  • NCT05134857 · 205 participants · Phase 2

    The Zonisamide and Reinforcement for Reducing Alcohol Use (ZARRA) Study

  • NCT05181891 · 205 participants · Phase 2

    Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking

  • NCT05283811 · 205 participants · NA

    Understanding Prefrontal and Medial Temporal Neuronal Responses to Algorithmic Cognitive Variables in Epilepsy Patients

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04806165, the US trial registry maintained by the National Library of Medicine. NCT04806165 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.